187 related articles for article (PubMed ID: 33036060)
1. Should "suspicious for high-grade urothelial carcinoma" and "positive for high-grade urothelial carcinoma" remain separate categories?
Nguyen L; Nilforoushan N; Krane JF; Bose S; Bakkar R
Cancer Cytopathol; 2021 Feb; 129(2):156-163. PubMed ID: 33036060
[TBL] [Abstract][Full Text] [Related]
2. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value below 0.7 for positive for high-grade urothelial carcinoma and suspicious for high-grade urothelial carcinoma in urine cytology specimens.
McIntire PJ; Snow JT; Elsoukkary SS; Soong L; Sweeney J; Robinson BD; Siddiqui MT
Cancer Cytopathol; 2019 Feb; 127(2):120-124. PubMed ID: 30395388
[TBL] [Abstract][Full Text] [Related]
3. Utility of the Paris System in Urine Cytology for Improved Screening of High-Grade Urothelial Carcinoma in Bahrain.
Mahmoud Daoud R; Ali AH; Salim Fredericks S; Daoud S; Gomaa HR; AlHashimi FS
Cureus; 2024 Mar; 16(3):e57189. PubMed ID: 38681345
[TBL] [Abstract][Full Text] [Related]
4. The predictive value of positive and suspicious urine cytology: Are they different?
Kuan KC; Segura SE; Ahlstedt J; Khader SN; Hakima L
Diagn Cytopathol; 2020 Nov; 48(11):998-1002. PubMed ID: 32558388
[TBL] [Abstract][Full Text] [Related]
5. Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.
Khajir G; Sun T; Wang H; Sprenkle PC; Adeniran AJ; Cai G; Levi AW
Cytopathology; 2024 Mar; 35(2):235-241. PubMed ID: 37916579
[TBL] [Abstract][Full Text] [Related]
6. The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH.
Vlajnic T; Gut A; Savic S; Bubendorf L
J Clin Pathol; 2020 Feb; 73(2):90-95. PubMed ID: 31467041
[TBL] [Abstract][Full Text] [Related]
7. Atypical Category of the Johns Hopkins Template Has Higher Risk of Malignancy than the Paris System but the Paris System Is More Applicable for Suspicious Category.
Celik B; Kavas G
Acta Cytol; 2023; 67(4):425-433. PubMed ID: 36731438
[TBL] [Abstract][Full Text] [Related]
8. The Paris system classification for urinary cytology in patients under bacillus Calmette-Guerin treatment.
Moulavasilis N; Stravodimos K; Meletis E; Levis P; Leftheriotis V; Lazaris A; Constantinides C; Mikou P
Diagn Cytopathol; 2022 Jun; 50(6):289-294. PubMed ID: 35262275
[TBL] [Abstract][Full Text] [Related]
9. [Practical application of the Paris system for reporting urinary cytology].
Chen L; Liu LT; Sun MJ; He SR; Liu DG
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):470-476. PubMed ID: 38678328
[No Abstract] [Full Text] [Related]
10. Implementation of The Paris System for Reporting Urine Cytology improves diagnostic accuracy of selective upper urinary tract cytology.
Miyai K; Nakayama M; Minabe S; Ogata S; Ito K; Matsukuma S
Cancer Cytopathol; 2024 Apr; 132(4):242-249. PubMed ID: 38294961
[TBL] [Abstract][Full Text] [Related]
11. Effect of the Paris system for reporting urinary cytology with histologic follow-up.
Rohra P; Ocampo Gonzalez FA; Yan L; Mir F; Furlan K; Basu S; Barua A; Cheng L; Park JW
Diagn Cytopathol; 2021 Jun; 49(6):691-699. PubMed ID: 33600080
[TBL] [Abstract][Full Text] [Related]
12. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
[TBL] [Abstract][Full Text] [Related]
13. Impact of the Paris system for reporting urine cytopathology on predictive values of the equivocal diagnostic categories and interobserver agreement.
Bakkar R; Mirocha J; Fan X; Frishberg DP; de Peralta-Venturina M; Zhai J; Bose S
Cytojournal; 2019; 16():21. PubMed ID: 31741668
[TBL] [Abstract][Full Text] [Related]
14. Methylation study of the Paris system for reporting urinary (TPS) categories.
Pierconti F; Martini M; Cenci T; Fiorentino V; Sacco E; Bientinesi R; Pugliese D; Iacovelli R; Schinzari G; Larocca LM; Bassi PF
J Clin Pathol; 2021 Feb; 74(2):102-105. PubMed ID: 32527754
[TBL] [Abstract][Full Text] [Related]
15. The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection.
Zheng X; Si Q; Du D; Harshan M; Zhang Z; Haines K; Shi W; Chhieng DC
Cytopathology; 2018 Apr; 29(2):184-188. PubMed ID: 29251368
[TBL] [Abstract][Full Text] [Related]
16. Significant reduction of indeterminate (atypical) diagnosis after implementation of The Paris System for Reporting Urinary Cytology: A single-institution study of more than 27,000 cases.
Tian W; Shore KT; Shah RB
Cancer Cytopathol; 2021 Feb; 129(2):114-120. PubMed ID: 32931158
[TBL] [Abstract][Full Text] [Related]
17. The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration.
Pierconti F; Rossi ED; Straccia P; Fadda G; Larocca LM; Bassi PF; Sacco E; Schinzari G
Cancer Cytopathol; 2018 Mar; 126(3):200-206. PubMed ID: 29360198
[TBL] [Abstract][Full Text] [Related]
18. Clinical follow up and the impact of the Paris system in the assessment of patients with atypical urine cytology.
Northrup V; Acar BC; Hossain M; Acker MR; Manuel E; Rahmeh T
Diagn Cytopathol; 2018 Dec; 46(12):1022-1030. PubMed ID: 30375194
[TBL] [Abstract][Full Text] [Related]
19. Application of the Paris Reporting System for Urine Cytology: The Three-Year Experience of a Single Tertiary Care Institute in Thailand.
Phruttinarakorn B; Plumworasawat S; Kayankarnnavee J; Lualon J; Pongtippan A
Acta Cytol; 2022; 66(2):134-141. PubMed ID: 34999581
[TBL] [Abstract][Full Text] [Related]
20. Experience on the use of The Paris System for Reporting Urinary Cytopathology: review of the published literature.
Pastorello RG; Barkan GA; Saieg M
J Am Soc Cytopathol; 2021; 10(1):79-87. PubMed ID: 33160893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
